Bayer’s Incoming CEO Faces Consumer Health Decision
Executive Summary
Activist investors are pushing for a break-up of Bayer's conglomerate structure and the sale of its Consumer Health division. It will be up to incoming CEO Bill Anderson to make the call.
You may also be interested in...
Euro Q4 Consumer Health Earnings Preview: Sanofi, Bayer, Haleon, Reckitt
Major Europe-based consumer health players Sanofi, Bayer, Haleon and Reckitt all feature in this sales and earnings preview, which highlights what to look out for and potential talking points as these four companies report Q4 and full-year results over the coming weeks.
Bayer Consumer Health's Future Undecided As Firm Kicks Off Strategic Review
Bayer's new CEO says nothing is off the table when it comes to assessing the future direction of the business. As part of a company-wide strategic review, he and his executive team will decide whether to break up or keep in place Bayer's three pillar structure, comprising Consumer Health, Pharmaceuticals and Crop Science.
Euro Q2 Consumer Health Earnings Preview: Bayer, Reckitt, Haleon, Sanofi
Major Europe-based consumer health players Bayer, Reckitt, Haleon and Sanofi all feature in this sales and earnings preview, which highlights what to look out for as these four firms report their Q2 2023 results over the coming weeks.